Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC–MS/MS for therapeutic drug monitoringMenghua Zhang, Liyan Miao, Lin Wang et al.|Journal of Pharmaceutical and Biomedical Analysis|2021Cited by 18
Method Development and Validation for Simultaneous Determination of Six Tyrosine Kinase Inhibitors and Two Active Metabolites in Human Plasma Using UPLC–MS/MS for Therapeutic Drug MonitoringMenghua Zhang, Liyan Miao, Xiaoxue Liu et al.|SSRN Electronic Journal|2021Cited by 0